Are companion diagnostics becoming a “must have” for market access?
Companion Diagnostics (CDx) are playing an increasingly vital role in market access by supporting product value claims and improving patient outcomes. What are the upsides for developers, pharma, payers and physicians and how can the challenges around new technology adoption, reimbursement and clinician uptake be overcome?
To really understand the issues and trends that are shaping the CDx market, senior managers in diagnostic development companies and the pharma industry should turn to this report.
“Pharma companies around the world are scouring tumour cells to find something different. It’s logical that detecting those differences would in fact then be down to a companion diagnostic.” Rob Steitz, Insight Genetics Inc.
Answering key questions:
With this report you will be able to:
Key Topics Explored:
All respondents met FirstWord’s stringent screening criteria, and were compensated for participating. To encourage frank and forthright responses, their names have been withheld.
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.
Table of Contents
for Trends and Innovations in Companion Diagnostics [Published by FirstWord Pharma]
1 Executive Summary
2 Research Objectives
2.1 Research Methodology
3 Setting the scene
4 Clinical and economic benefits of developing a companion diagnostic
5 Recent innovations in precision medicine and companion diagnostics
6 Recent technological innovations in companion diagnostics
7 Drivers and inhibitors for the uptake of CDx
8 Factors influencing successful/unsuccessful partnerships
9 Optimal and sub-optimal practice for developing companion diagnostics
10 Regulatory impact on the development and uptake of CDx
11 Managing stakeholder expectations on CDx programmes
12 What needs to be done to encourage future innovation in CDx development?
13 Future opportunities in CDx and precision medicines
|Title||Date Published||Price from||More Details|
|Drug Delivery - Innovations, trends, and their impact on pharma|
IntroductionWhy you need Drug Delivery - Innovations, trends, and their impact on pharmaRevolutionar...
|01 Nov 2015 by FirstWord Pharma||USD $2,195||More Info|
|Trends and Innovations in Key Account Management|
IntroductionYour customers need and demand more from you today. Key Account Management (KAM) is the ...
|01 Jul 2015 by FirstWord Pharma||USD $695||More Info|
|Physician Views: Assessing new competitive trends in the oral anticoagulant market|
ScopeThe new class of oral anticoagulants – comprising the Factor Xa inhibitors Xarelto (Bayer/Johns...
|01 Jun 2015 by FirstWord Pharma||USD $695||More Info|
|Trends & Innovations Sales Force Effectiveness|
IntroductionWhat makes an ideal modern pharma sales representative and what skills, knowledge, tools...
|01 Apr 2015 by FirstWord Pharma||USD $695||More Info|
|Trends and Innovations in Patient Adherence|
IntroductionTaking the right dose of the right medicine at the right time is key to improving health...
|01 Mar 2015 by FirstWord Pharma||USD $695||More Info|
|Trends and Innovations in Lifecycle Management|
IntroductionTrends and Innovations in Lifecycle Management (LCM) presents business-critical insights...
|01 Feb 2015 by FirstWord Pharma||USD $695||More Info|
|Trends and Innovations in Drug Pricing|
IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends ...
|01 Jan 2015 by FirstWord Pharma||USD $695||More Info|
|Trends in Measuring and Rewarding KAM Team Performance|
IntroductionKey account managers (KAMs) are the new face of pharma sales. Whether meeting with hospi...
|24 Nov 2014 by FirstWord Pharma||USD $695||More Info|
|Therapy Trends: Alzheimer's Disease - Breaking new ground in disease modification|
IntroductionIn 2012, the Alzheimer’s disease (AD) market was dealt a huge blow following negative re...
|01 Dec 2012 by FirstWord Pharma||USD $7,900||More Info|
|Pricing and Reimbursement Trends in the US: Impact of Comparative Effectiveness Research and Cost-Effectiveness Analysis|
IntroductionPublic healthcare costs are rising. Governments need to get them under control. In Europ...
|01 Jan 2012 by FirstWord Pharma||USD $695||More Info|
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.